Public filings / CVS on Yahoo Finance (opens in a new tab)
CVS: insider buying, 13F holders, analyst moves
CVS Health Corp
A summary of public filings about CVS Health Corp. For the latest insider history, price chart, analyst changes and activist filings, open the live lookup.
SEC Form 13F · Q2 2026
5 of our 100 managers hold CVS
Combined reported value $2.42B; 3 sold out since Q1 2026.
Holders among our 100 managers: 5 in Q3 2023, 5 in Q2 2026.
| Manager | Value | % of portfolio | Change vs Q1 2026 |
|---|---|---|---|
| Davis Selected Advisers | $1.23B | 5.27% | Trimmed |
| Glenview Capital | $499.1M | 9.97% | Trimmed |
| Viking Global Investors | $379.0M | 1.08% | New |
| Fairfax Financial | $280.5M | 10.63% | Unchanged |
| Tudor Investment | $38.3M | 0.16% | Trimmed |
Important information
Facts from public SEC filings, shown for information only. Not a recommendation. Not individualized investment advice. Gulfstream Capital and its clients may hold positions in securities shown.